Why the study?
Doxorubicin induces dose-dependent cardiotoxicity, but the potential efficacy of Guizhi Gancao Decoction against this cardiotoxicity remained unexplored.
Does Guizhi Gancao Decoction prevent doxorubicin-induced cardiotoxicity in mice and cardiomyocytes?
Does Guizhi Gancao Decoction prevent doxorubicin-induced cardiotoxicity in mice and cardiomyocytes?
Guizhi Gancao Decoction protects against doxorubicin-induced cardiotoxicity by inhibiting HDAC6-mediated α-tubulin deacetylation, stabilizing microtubules and preserving calcium handling.
Should not change clinical practice; hypothesis-generating for HDAC6 inhibition in anthracycline cardiotoxicity.
No takes yet. Share an insight, caveat, or question.
Its licence doesn't allow us to show a copy here.
Yao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: